Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Kangmei Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

¥5.1 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue16.6B11.1B5.1B3.4B4.0B5.1B5.1B5.1B
Cost of goods sold11.6B9.9B5.2B3.5B3.5B4.0B4.4B4.2B
Gross profit5.3B1.3B62.6M12.7M437.8M1.1B699.3M985.7M
Gross profit margin, %11.6%1.2%0.4%11.0%21.7%13.8%19.2%
Operating expense total2.6B1.9B1.5B(307.0M)798.9M837.9M815.8M836.1M
Depreciation and amortization921.5M2.0B2.9B583.8M260.4M204.0M324.8M
EBITDA2.7B(531.2M)(1.4B)319.7M(361.2M)268.1M(116.5M)149.6M
EBITDA margin, %-4.8%-27.4%9.4%-9.1%5.3%-2.3%2.9%
EBIT2.5B(2.9B)(28.8B)9.0B(2.6B)93.1M(19.3M)(37.6M)
EBIT margin, %-26.1%-560.5%265.6%-66.2%1.8%-0.4%-0.7%
Interest income17.9M5.2M2.2M5.3M40.0M30.7M17.2M10.5M
Interest expense1.8B2.2B2.2B1.0B78.9M56.2M21.4M18.7M
Pre tax profit672.5M(4.4B)(31.0B)8.2B(2.7B)110.4M34.7M43.1M
Income tax expense302.4M264.1M62.5M235.4M29.8M6.8M22.6M30.7M
Net Income370.0M(4.7B)(31.1B)7.9B(2.7B)103.6M12.1M12.4M

Footer menu